Company:  SIMULATIONS PLUS INC (SLP)
Form Type:  10-Q
Filing Date:  1/17/2012 
CIK:  0001023459 
Address:  42505 10TH STREET WEST
*
 
City, State, Zip:  LANCASTER, California 93534-7059 
Telephone:  661-723-7723 
Fiscal Year:  08/31 
Last Trade
Last Trade: 
$6.39  
Change: 
-0.06 (-0.93%)  
Trade Time: 
Dec 19  
Market Cap: 
N/A
Description of Business
As used in this report, each of the terms �we,� �us,� �our,� the �Company� and �Simulations Plus� refers to Simulations Plus, Inc. and Cognigen Corporation, unless otherwise stated or the context otherwise requires. OVERVIEW Simulations Plus, Inc., incorporated in 1996, is a premier developer of groundbreaking drug discovery and development software for mechanistic modeling and simulation. Our software is licensed to major pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies worldwide for use in the conduct of industry-based research. We also provide consulting services to these industries. Recently, we have been exploring the application of some of our machine-learning technologies for problems in aerospace and healthcare outside of our traditional markets. Simulations Plus is headquartered in Southern California and its common stock trades on the NASDAQ Capital Market under the symbol �SLP.
Register for a Free Trial and access this filing in:     
  FORM 10-Q
    Note 10: SUBSEQUENT EVENT
    PART I
      Item 2. Management's Discussion and Analysis or Plan of ...
      Item 3. Quantitative and Qualitative Disclosures about ...
      Item 4. Controls and Procedures
    Part II. Other Information
      Item 1. Legal Proceedings
      Item 2. Changes in Securities
      Item 3. Defaults Upon Senior Securities
      Item 4. Submission of Matters to a Vote of Security Holders
      Item 5. Other Information
      Item 6. Exhibits
    SIGNATURE
  EXHIBIT 31.1
    RULE 13A-14(A) CERTIFICATION
  EXHIBIT 31.2
    RULE 13A-14(A) CERTIFICATION
  EXHIBIT 32
    CERTIFICATIONS PURSUANT TO